Vicarious Surgical Inc. (RBOT)
USD 12.46
(-10.1%)
USD 12.46
(-10.1%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -71.07 Million USD | -179.71% |
| 2022 | 89.15 Million USD | 1366.25% |
| 2021 | -7.04 Million USD | 45.33% |
| 2020 | -12.87 Million USD | -38.26% |
| 2019 | -9.31 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -15.2 Million USD | 10.56% |
| 2024 Q1 | -17 Million USD | -29.67% |
| 2023 FY | -71.07 Million USD | -179.71% |
| 2023 Q4 | -13.11 Million USD | 16.51% |
| 2023 Q3 | -15.7 Million USD | -2.41% |
| 2023 Q1 | -32.56 Million USD | -1217.69% |
| 2023 Q2 | -15.33 Million USD | 52.91% |
| 2022 Q3 | -27.77 Million USD | -1811.56% |
| 2022 Q4 | -2.47 Million USD | 91.1% |
| 2022 FY | 89.15 Million USD | 1366.25% |
| 2022 Q2 | -1.45 Million USD | -101.41% |
| 2022 Q1 | 103.25 Million USD | 47.34% |
| 2021 Q1 | -5.23 Million USD | -38.24% |
| 2021 FY | -7.04 Million USD | 45.33% |
| 2021 Q4 | 70.08 Million USD | 207.03% |
| 2021 Q3 | -65.47 Million USD | -886.43% |
| 2021 Q2 | -6.63 Million USD | -26.9% |
| 2020 Q4 | -3.78 Million USD | -13.26% |
| 2020 Q1 | -2.7 Million USD | 0.0% |
| 2020 Q3 | -3.34 Million USD | -9.65% |
| 2020 FY | -12.87 Million USD | -38.26% |
| 2020 Q2 | -3.04 Million USD | -12.73% |
| 2019 FY | -9.31 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 101.242% |
| Allurion Technologies Inc. | -82.3 Million USD | 13.648% |
| Artivion, Inc. | -30.69 Million USD | -131.577% |
| Avanos Medical, Inc. | -61.8 Million USD | -15.002% |
| Butterfly Network, Inc. | -133.69 Million USD | 46.843% |
| Butterfly Network, Inc. | -133.69 Million USD | 46.843% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 88.849% |
| Boston Scientific Corporation | 1.59 Billion USD | 104.461% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | -384.465% |
| CONMED Corporation | 64.45 Million USD | 210.258% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 105.068% |
| Paragon 28, Inc. | -47.84 Million USD | -48.557% |
| Glaukos Corporation | -134.66 Million USD | 47.222% |
| Globus Medical, Inc. | 122.87 Million USD | 157.841% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | -235.985% |
| Integer Holdings Corporation | 90.65 Million USD | 178.402% |
| Medtronic plc | 3.67 Billion USD | 101.933% |
| Nevro Corp. | -92.21 Million USD | 22.927% |
| Owlet, Inc. | -32.9 Million USD | -116.015% |
| Penumbra, Inc. | 90.95 Million USD | 178.139% |
| Smith & Nephew plc | 263 Million USD | 127.023% |
| Sonendo, Inc. | -60.91 Million USD | -16.665% |
| STERIS plc | 378.23 Million USD | 118.79% |
| Stryker Corporation | 3.16 Billion USD | 102.246% |
| Vapotherm, Inc. | -58.19 Million USD | -22.13% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 106.941% |